Nanomedx

medical devices

About

Nanomedx has developed a novel carbon-based nanoparticle which can be utilised for multiple clinical applications to address some of the most pressing challenges in modern medicine. The Nanomedx platform is built on the scientific discovery of Professor Steven Wise and his team at University of Sydney. The technology and the associated IP has been further researched and adapted for clinical applications at the Heart Research Institute (HRI) in Sydney and has received funding from the National Foundation for Medical Research and Innovation (NFMRI) and the Targeted Translation Research Accelerator (TTRA). Nanomedx has a clear objective of establishing itself as the global leader in medical nanoparticle technology and ensuring that the myriad therapies developed on the back of the platform will result in unprecedented clinical benefits for patients around the world.

Technologies

Gmail Google Apps Google Cloud Hosting Wix Mobile Friendly Varnish

Keywords

medical equipment manufacturing next-gen therapeutics therapy medical imaging diagnostics services nanoparticle technology next-generation biomedical multifunctional nanoparticles therapeutic applications biomedical imaging patented nanotech biomedical innovation biomedical applications b2b revolutionize nanomedicine medical devices medical diagnostics healthcare nanomedicine nanotechnology research and development in the physical engineering and life sciences biotechnology nanoparticle efficiency biotech biomedical medical research drug delivery

Location

Sydney, New South Wales, Australia, 2008

Related Companies

Companies in the same industry